Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03895671
Title PONAZA : A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST CRISIS (PONAZA)
Acronym PONAZA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Versailles Hospital
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.